Clever Leaves Holdings (CLVR) Peer Comparison
$0.00
As on 04-Sep-2026 09:30EDT
Market cap
$0 Mln
Revenue (TTM)
$18 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
| Clever Leaves Holdings (CLVR) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
-- | 2,453 | 1,201 | 1,004 | 337 |
Revenue ($ Mln) |
18 | 10,853 | 243 | 182 | 928 |
Net Profit ($ Mln) |
-18.90 | -1,098.00 | 69.79 | 153.05 | -21.69 |
Net Margin (%) |
-104.57 | -10.12 | 28.74 | 84.23 | -2.34 |
RoE (%) |
-70.13 | -- | 5.60 | 91.29 | -2.00 |
Price to Earnings |
-- | -- | 17.16 | 6.42 | -- |
Price-To-Book |
-- | 18.78 | 1.12 | 3.96 | 0.44 |
Cashflow ($ Mln)
| Clever Leaves Holdings (CLVR) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-11.51 | 1,032.00 | -42.84 | -85.94 | -16.65 |
|
Cash Flow from Investing Activities
|
4.69 | -2,145.00 | -59.50 | 50.77 | -24.82 |
|
Cash from Financing Activities
|
0.66 | 1,475.00 | -1.03 | 30.65 | -43.08 |
|
Net Cash Inflow / Outflow
|
-- | -1,505.00 | -- | -78.48 | -- |
Ratios
Profitability Ratios
| Clever Leaves Holdings (CLVR) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-50.73 | -2.86 | -6.57 | -55.16 | -12.09 |
|
ROE (%)
|
-70.13 | 69.08 | -6.59 | -59.99 | -13.71 |
|
ROA (%)
|
-38.10 | -2.23 | -6.29 | -42.88 | -11.39 |
|
EBIT Margin (%)
|
-85.83 | -- | -- | -- | -- |
|
Net Margin (%)
|
-104.57 | -6.76 | -84.78 | -401.57 | -18.99 |
|
Cash Profit Margin (%)
|
0.00 | -- | -- | -- | -- |
Growth Ratios
| Clever Leaves Holdings (CLVR) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
16.18 | 0.08 | 0.01 | -0.54 | 0.28 |
|
EBIT Growth (%)
|
68.00 | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
65.06 | -163.11 | 56.17 | -4.89 | 48.48 |
|
EPS Growth (%)
|
69.40 | -1.61 | 0.56 | 0.04 | 0.55 |
|
Book Value Growth (%)
|
-44.17 | -- | -- | -- | -- |
Valuation Ratios
| Clever Leaves Holdings (CLVR) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-0.20 | -4.95 | -10.77 | -5.78 | -2.50 |
|
Price / Book Value
|
0.15 | -2.87 | 0.72 | 3.97 | 0.36 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
0.07 | 8.45 | 0.87 | -4.28 | -4.00 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Clever Leaves Holdings (CLVR) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | -21.91 | 0.00 | 0.08 | 0.14 |
|
Short term debt to equity ratio
|
0.04 | -0.44 | 0.00 | 0.00 | 0.03 |
|
Current Ratio
|
2.40 | 1.30 | 22.54 | 5.87 | 3.94 |
|
Quick Ratio
|
1.63 | 0.94 | 21.81 | 5.95 | 2.69 |
|
Interest Coverage
|
-238.81 | 1.22 | -8,030.00 | -157.71 | -20.72 |
Operating Efficiency Ratios
| Clever Leaves Holdings (CLVR) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
11.50 | 22.82 | 41.13 | 9.79 | 2.98 |
|
Asset Turnover
|
0.36 | 0.33 | 0.07 | 0.11 | 0.60 |
|
Receivable days
|
66.46 | 79.00 | 140.61 | 31.49 | 9.98 |
|
Inventory Days
|
216.61 | 187.98 | 164.98 | -11.52 | 66.27 |
|
Payable days
|
73.35 | 88.49 | 56.47 | 16.71 | 8.08 |
|
Cash Conversion Cycle
|
209.72 | 178.48 | 249.13 | 3.26 | 68.17 |